Xoburik Forte Tablet contains Alpha Ketoanalogue (NA), a specialized nutritional supplement designed to support patients with chronic kidney disease (CKD) by providing essential ketoanalogues of amino acids. These compounds serve as nitrogen-free precursors that the body can convert into essential amino acids, thereby helping to reduce the nitrogen load and delay the progression of renal impairment. Xoburik Forte is primarily indicated for use in conjunction with a low-protein diet to manage metabolic imbalances and minimize uremic symptoms in patients with moderate to severe renal insufficiency. By supplementing with Alpha Ketoanalogue, the tablet aids in maintaining nutritional status while reducing the accumulation of nitrogenous waste products, which can exacerbate kidney dysfunction. This therapeutic approach helps to improve patient outcomes by slowing the decline of glomerular filtration rate (GFR) and postponing the need for dialysis. Xoburik Forte should be administered under medical supervision, with dosage adjustments based on the severity of renal impairment and dietary protein intake. It is contraindicated in patients with hypersensitivity to any component of the formulation. Regular monitoring of renal function and nutritional parameters is recommended during treatment to ensure efficacy and safety.